These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10330589)

  • 1. [Physical criteria of pathological processes. III. Structure of the correlation between the level of steady brain potential with serum complement proteins in rheumatic diseases].
    Klimenko LL; Kozlov LV; Kudriashova LP; Protasova OV; Maksimova IA; Komarova MN; Konradov AA; Turna AA; Soiustova EL; Matveev GN
    Biofizika; 1999; 44(1):128-31. PubMed ID: 10330589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum complement activity. Clinical and humoral correlations].
    Purice S; Ghelerter L; Drăgoi T; Lungu N
    Med Interna (Bucur); 1969 Feb; 21(2):173-80. PubMed ID: 5780235
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of complement in serum and synovial fluid in rheumatic diseases].
    Gangl A; Thumb N
    Wien Z Inn Med; 1968; 49(7):251-7. PubMed ID: 5737587
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of synovial fluid total hemolytic complement activity.
    Kim HJ; McCarty DJ; Kozin F; Koethe S
    J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The level of serum thymic activity in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Ternovoĭ KS; Selezneva TN; Gandzha IM; Babynina LIa; Skorik AIu; Ermekova VM
    Ter Arkh; 1993; 65(8):66-7. PubMed ID: 8211807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C; Andreis M; Bennett L; Godoy G
    Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of reduced complement level in the articular fluid. 81 cases].
    Del Pino Montes J; Meyer O; Borda Iriarte O; Belenguer Prieto R; Peltier AP; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):19-21. PubMed ID: 6601817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of estrogen-androgen imbalance in rheumatic diseases].
    Alekberova ZS; Folomeev MIu; Polyntsev IuV
    Ter Arkh; 1990; 62(5):17-21. PubMed ID: 2396214
    [No Abstract]   [Full Text] [Related]  

  • 10. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
    Telegina E; Reshetnyak T; Moshnikova A; Proussakova O; Zhukova A; Kuznetsova A; Ivanov A; Paltsev M; Beletsky I
    Immunol Lett; 2009 Jan; 122(1):12-7. PubMed ID: 19010354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.
    Hedberg H; Lundh B; Laurell AB
    Clin Exp Immunol; 1970 May; 6(5):707-12. PubMed ID: 5477926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topics in clinical medicine. Complement levels in disease.
    Townes AS
    Johns Hopkins Med J; 1967 May; 120(5):337-43. PubMed ID: 6024563
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus evolving into rheumatoid arthritis.
    Rothfield NF; Lim AA
    J Rheumatol; 2006 Jan; 33(1):188-90. PubMed ID: 16395767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical importance of complement research in rheumatic diseases].
    Tanner E; Wessel G
    Z Gesamte Inn Med; 1980 Dec; 35(24):191-2 contd. PubMed ID: 6971535
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement and complement components in diseases of possible auto-immunological pathogenesis.
    JONSEN J; KASS E
    Acta Rheumatol Scand; 1961; 7():21-6. PubMed ID: 13790639
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and properdin: biologic and clinical importance.
    Ruddy S
    Orthop Clin North Am; 1975 Jul; 6(3):609-17. PubMed ID: 1099503
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physical criteria of pathological processes. II. Modulating role of functional interhemisphere asymmetry in forming and immune response in rheumatic diseases].
    Klimenko LL; Kudriashova LP; Protasova OV; Maksimova IA; Komarova MN; Soiustova EL; Turna AA; Matveev GN; Fokin VF
    Biofizika; 1998; 43(6):1066-70. PubMed ID: 10079926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.